UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 709

Sortiert nach

IL-12-Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivo

Annals of the New York Academy of Sciences, 1996-10, Vol.795 (1), p.284-293

1996

Volltextzugriff (PDF)

IL‐12‐Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivoa

Annals of the New York Academy of Sciences, 1996-10, Vol.795 (1), p.284-293

1996

Volltextzugriff (PDF)

IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, Pennsylvania

Human gene therapy, 1995-12, Vol.6 (12), p.1607-1624

1995

Volltextzugriff (PDF)

1510 Multiomic functional biomarkers for cancer prediction and early detection

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 2), p.A1732-A1732

2023

Volltextzugriff (PDF)

IL-18-elicited regulatory NK cells with immunoablative functions (40.22)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.40-40.22

2009

Volltextzugriff (PDF)

IL‐2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes

European Journal of Immunology, 2005-10, Vol.35 (10), p.2840-2850

2005

Volltextzugriff (PDF)

IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules

The Journal of immunology (1950), 2004-05, Vol.172 (10), p.5957-5966

2004

Volltextzugriff (PDF)

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A945-A945

2021

Volltextzugriff (PDF)

About Ralph M. Steinman and dendritic cells

M.S. Médecine sciences, 2011-11, Vol.27 (11), p.1028

2011

Volltextzugriff (PDF)

Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy

Oncoimmunology, 2012-07, Vol.1 (4), p.407-408

2012

Volltextzugriff (PDF)

Abstract B037: Macrophage repolarization therapy in metastatic colorectal cancer: CCR5 inhibition

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.B037-B037

2016

Volltextzugriff (PDF)

Abstract CN2-1: Personalized chemotherapy of cancer based on immune parameters

Clinical cancer research, 2010-04, Vol.16 (7_Supplement), p.CN2-1-CN2-1

2010

Volltextzugriff (PDF)

Abstract IA17: Gut microbiota controls immuneresponses during cancer therapy

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.IA17-IA17

2016

Volltextzugriff (PDF)

Abstract IA22: The unsuspected role of gut microbiota in cancer therapies: Antigen mimicry between intestinal phage and tumor antigens

Cancer immunology research, 2020-03, Vol.8 (3_Supplement), p.IA22-IA22

Zitvogel, Laurence

2020

Volltextzugriff (PDF)

acDCs enhance human antigen–specific T-cell responses

Blood, 2011-08, Vol.118 (8), p.2128-2137

2011

Volltextzugriff (PDF)

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

Nature Medicine, 2009-10, Vol.15 (10), p.1170-1178

2009

Volltextzugriff (PDF)

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors

Nature medicine, 2009-10, Vol.15 (10), p.1170-1178

2009

Volltextzugriff (PDF)

Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects

Cytokines, cellular & molecular therapy., 1998-03, Vol.4 (1), p.53

1998

Volltextzugriff (PDF)

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Nature Medicine, 2011-06, Vol.17 (6), p.700-707

2011

Volltextzugriff (PDF)

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort

Oncoimmunology, 2013-03, Vol.2 (3), p.e23472-e23472

2013

Volltextzugriff (PDF)

Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy

NPJ precision oncology, 2024-07, Vol.8 (1), p.143-9, Article 143

2024

Volltextzugriff (PDF)

Antibiotics impair immunotherapy for urothelial cancer

Nature reviews. Urology, 2020-11, Vol.17 (11), p.605

2020

Volltextzugriff (PDF)

Antibiotics prescription to decrease progression-free survival (PFS) and overall survival (OS) in patients with advanced cancers treated with PD1/PDL1 immune checkpoint inhibitors

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3015-3015

2017

Volltextzugriff (PDF)

Antibodies regulate antitumour immunity

Nature (London), 2015-05, Vol.521 (7550), p.35-37

2015

Volltextzugriff (PDF)

1 – 25 von 709

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(581)
Mit Volltextzugriff
(636)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Oncoimmunology
(151)
Nature Medicine
(27)
Science
(17)
The Journal Of Clinical Investigation
(16)
The Journal Of Experimental Medicine
(16)
The Journal Of Immunology
(16)
The journal Of Immunology/the journal Of Immunology
(14)
Blood
(13)
Cancer Discovery
(13)
Immunity
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

IL-12-Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivo

IL‐12‐Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivoa

IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts. University of Pittsburgh, Pittsburgh, Pennsylvania

1510 Multiomic functional biomarkers for cancer prediction and early detection

IL-18-elicited regulatory NK cells with immunoablative functions (40.22)

IL‐2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes

IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules

901 Bacillus Calmette-Guerin can subvert patients antitumor immune response by downregulating HLA-I expression on cancer cells

About Ralph M. Steinman and dendritic cells

Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy

Abstract B037: Macrophage repolarization therapy in metastatic colorectal cancer: CCR5 inhibition

Abstract CN2-1: Personalized chemotherapy of cancer based on immune parameters

Abstract IA17: Gut microbiota controls immuneresponses during cancer therapy

Abstract IA22: The unsuspected role of gut microbiota in cancer therapies: Antigen mimicry between intestinal phage and tumor antigens

acDCs enhance human antigen–specific T-cell responses

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1[beta]-dependent adaptive immunity against tumors

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors

Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort

Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy

Antibiotics impair immunotherapy for urothelial cancer

Antibiotics prescription to decrease progression-free survival (PFS) and overall survival (OS) in patients with advanced cancers treated with PD1/PDL1 immune checkpoint inhibitors

Antibodies regulate antitumour immunity

Aktive Filter

Suchergebnisse filtern